Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
Aurélie Collignon, Teodora‐Adriana Perles‐Barbacaru, Stéphane Robert, et al.
Oncotarget (2015) Vol. 6, Iss. 27, pp. 23462-23479
Open Access | Times Cited: 17

Showing 17 citing articles:

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. Mace, Reena Shakya, Jason R. Pitarresi, et al.
Gut (2016) Vol. 67, Iss. 2, pp. 320-332
Open Access | Times Cited: 445
Altered glycosylation in pancreatic cancer and beyond
Jan Lumibao, Jacob R. Tremblay, Jasper Hsu, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 49
Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer
Li Xiao, Ulrike Erb, Kun Zhao, et al.
OncoImmunology (2017) Vol. 6, Iss. 6
Open Access | Times Cited: 82
How grim is pancreatic cancer?
Elroy Patrick Weledji, George Enow-Orock, Martin Mokake, et al.
Oncology Reviews (2016)
Open Access | Times Cited: 42
Targeting dendritic cells in pancreatic ductal adenocarcinoma
Anton Deicher, Roland Andersson, Bobby Tingstedt, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 33
Dendritic cell vaccines: A review of recent developments and their potential pediatric application
Jennifer Elster, Deepa Kolaseri Krishnadas, Kenneth G. Lucas
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 9, pp. 2232-2239
Open Access | Times Cited: 32
Pancreatic cancer models for translational research
Diana Behrens, Wolfgang Walther, Iduna Fichtner
Pharmacology & Therapeutics (2017) Vol. 173, pp. 146-158
Closed Access | Times Cited: 29
Animal models for modeling pancreatic cancer and novel drug discovery
Savita Bisht, Georg Feldmann
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 2, pp. 127-142
Closed Access | Times Cited: 17
Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, et al.
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 12, pp. 2931-2952
Open Access | Times Cited: 15
Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models.
Liang Pan, Na Shang, Junjie Shangguan, et al.
PubMed (2019) Vol. 9, Iss. 3, pp. 562-573
Closed Access | Times Cited: 14
<p>Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer</p>
Samaneh Tokhanbigli, Ali Asadirad, Kaveh Baghaei, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 95-104
Open Access | Times Cited: 13
Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers
Emmanuelle Martinez, Françoise Silvy, Frédéric Fina, et al.
Oncotarget (2015) Vol. 6, Iss. 37, pp. 39855-39864
Open Access | Times Cited: 11
Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.
Jia Yang, Su Hu, Junjie Shangguan, et al.
American Journal of Cancer Research (2019) Vol. 9, Iss. 11, pp. 2456-2468
Closed Access | Times Cited: 9
Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?
Dominique Lombardo, Françoise Silvy, Isabelle Crenon, et al.
Oncotarget (2017) Vol. 9, Iss. 15, pp. 12513-12533
Open Access | Times Cited: 8
Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma.
Aurélie Collignon, Françoise Silvy, Stéphane Robert, et al.
HAL (Le Centre pour la Communication Scientifique Directe) (2018) Vol. 7, Iss. 12, pp. e1504727-e1504727
Closed Access | Times Cited: 7
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
Michael A. White, Andrew Freistaedter, Gwendolyn J. B. Jones, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0193131-e0193131
Open Access | Times Cited: 3
Delivery strategies for cancer vaccines and immunoadjuvants
Elizabeth G. Graham-Gurysh, Brandon Carpenter, Wolfgang Beck, et al.
Elsevier eBooks (2021), pp. 359-408
Closed Access | Times Cited: 2
Page 1

Scroll to top